Period 2 mutation accelerates ApcMin/+ tumorigenesis

Molecular Cancer Research

Volumn 6, Issue 11, 2008, Pages 1786-1793

  Wood, Patricia A ^a,b,d   Yang, Xiaoming ^a,d   Taber, Andrew ^a   Oh, Eun Young ^a   Ansell, Christine ^a   Ayers, Stacy E ^a   Al Assaad, Ziad ^b   Carnevale, Kevin ^a   Berger, Franklin G ^c,d   Peña, Maria Marjorette O ^c,d   Hrushesky, William J M ^a,d  

^a School of Medicine   (United States)

^b WJB Dorn VA Medical Center   (United States)

^c Department of Biological Sciences   (United States)

^d UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; BETA CATENIN; CYCLIN D; GENE PRODUCT; PER2 PROTEIN;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER CONTROL; CANCER PREVENTION; CELL PROLIFERATION; CELL STRAIN HCT116; CELL STRAIN HEK293; CIRCADIAN RHYTHM; COLON CARCINOGENESIS; COLON CARCINOMA; COLON POLYPOSIS; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE FUNCTION; GENE INACTIVATION; GENE MUTATION; HELA CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; INTESTINE MUCOSA; MALE; MOLECULAR CLOCK; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE; SPECIES COMPARISON; SPLENOMEGALY; WILD TYPE;

ANIMALS; BETA CATENIN; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CIRCADIAN RHYTHM; COLON; COLONIC NEOPLASMS; COLONIC POLYPS; CYCLINS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GENES, APC; HUMANS; INTESTINAL MUCOSA; INTESTINAL POLYPS; MICE; MUTATION; NEOPLASM INVASIVENESS; NUCLEAR PROTEINS; RNA INTERFERENCE; TRANSCRIPTION FACTORS;

MUS;

EID: 56449122777     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-08-0196     Document Type: Article

References (38)

1. Le e C, Etchegaray JP, Cagampang FR, Loudon AS, Reppert SM. Posttranslational mechanisms regulate the mammalian circadian clock. Cell 2001;107:855-67.
2. Y ou S, Wood PA, Xiong Y, Kobayashi M, Du-Quiton J, Hrushesky WJ. Daily coordination of cancer growth and circadian clock gene expression. Breast Cancer Res Treat 2005;91:47-60.
3. Wood PA, Du-Quiton J, You S, Hrushesky WJ. Circadian clock coordinates cancer cell cycle progression, thymidylate synthase, and 5-fluorouracil therapeutic index. Mol Cancer Ther 2006;5:2023-33.
4. Reppert SM, Weaver DR. Coordination of circadian timing in mammals. Nature 2002;418:935-41.
5. Wood PA, Du-Quiton J, You S, Hrushesky WJM. Circadian clock coordinates cancer cell cycle progression, thymidylate synthase, and 5-fluorouracil therapeutic index. Mol Cancer Ther 2006;5:2023-33.
6. Bjarnason GA, Jordan RC, Wood PA, et al. Circadian expression of clock genes in human oral mucosa and skin: association with specific cell-cycle phases. Am J Pathol 2001;158:1793-801.
7. Lincoln DW II, Hrushesky WJ, Wood PA. Circadian organization of thymidylate synthase activity in normal tissues: a possible basis for 5-fluorouracil chronotherapeutic advantage. Int J Cancer 2000;88:479-85.
8. Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H. Control mechanism of the circadian clock for timing of cell division in vivo. Science 2003;302:255-9.
9. Grechez-Cassiau A, Rayet B, Guillaumond F, Teboul M, Delaunay F. The circadian clock component BMAL1 is a critical regulator of p21WAF1/CIP1 expression and hepatocyte proliferation.J Biol Chem 2008;283:4535-42.
10. Buch i K, Moore J, Hrushesky W, Sothern R, Rubin N. Circadian rhythm of cellular proliferation in the human rectal mucosa.Gast roenterology 1991;101:410-5.
11. Neal JV, Potten CS. Circadian rhythms in the epithelial cells and the pericryptal fibroblast sheath in three different sites in the murine intestinal tract. Cell Tissue Kinet 1981;14:581-7.
12. Fu L, Pelicano H, Liu J, Huang P, Lee C. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 2002;111:41-50.
13. Fu L, Lee C. The circadian clock: pacemaker and tumor suppressor. Nat Rev Cancer 2003;3:350-61.
14. Sjoblom T, Jones S, Wood LD, et al. The consensus coding sequences of human breast and colorectal cancers.Science 2006;314:268-74.
15. Chen ST, Choo KB, Hou MF, Yeh KT, Kuo SJ, Chang JG. Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis 2005;26:1241-6.
16. Schernhammer ES, Laden F, Speizer FE, et al. Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J Natl Cancer Inst 2001;93:1563-8.
17. Schernhammer ES, Laden F, Speizer FE, et al. Night-shift work and risk of colorectal cancer in the nurses' health study.J Natl Cancer Inst 2003;95:825-8.
18. Viswanathan A, Hankinson S, Schernhammer ES. Night shift work and risk of endometrial cancer.Ca ncer Res 2007;67:10618-22.
19. Staif K, Baan R, Grosse Y, et al. Carcinogenicity of shift-work, painting and fire-fighting. Lancet Oncol 2007;8:1065-6.
20. Society AC. Cancer facts & figures 2007. Atlanta: American Cancer Society; 2007.
21. Kolligs FT, Bommer G, Goke B. Wnt/β-catenin/tcf signaling: a critical pathway in gastrointestinal tumorigenesis.Digestion 2002;66:131-44.
22. Schneikert J, Behrens J. The canonical Wnt signaling pathway and its APC partner in colon cancer development. Gut 2007;56:417-25.
23. Karim R, Tse G, Putti T, Scolyer R, Lee S. The significance of the Wnt pathway in the pathology of human cancers. Pathology 2004;36:120-8.
24. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
25. Moser AR, Pitot HC, Dove WF. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 1990;247:322-4.
26. You S, Ohmori M, Pena MM, et al. Developmental abnormalities in multiple proliferative tissues of ApcMin/+ mice.Int J Exp Pathol 2006;87:227-36.
27. Yang M, Zhong WW, Srivastava N, et al. G protein-coupled lysophosphatidic acid receptors stimulate proliferation of colon cancer cells through the β-catenin pathway. Proc Natl Acad Sci U S A 2005;102:6027-32.
28. Eide EJ, Woolf MF, Kang H, et al. Control of mammalian circadian rhythm by CKIε-regulated proteasome-mediated PER2 degradation. Mol Cell Biol 2005;25:2795-807.
29. Iitaka C, Miyazaki K, Akaike T, Ishida N. A role for glycogen synthase kinase-3β in the mammalian circadian clock.J Biol Chem 2005;280:29397-402.
30. Reischl S, Vanselow K, Westermark PO, et al. β-TrCP1-mediated degradation of PERIOD2 is essential for circadian dynamics. J Biol Rhythm 2007;22:375-86.
31. Gery S, Gombart AF, Yi WS, Koeffler C, Hofmann WK, Koeffler HP. Transcriptional profiling of C/EBP targets identifies Per2 as a gene implicated in myeloid leukemias.Blood 2005;106:2827-36.
32. Hua H, Wang Y, Wan C, et al. Inhibition of tumorigenesis by intratumoral delivery of the circadian gene mPer2 in C57BL/6 mice.Cancer Gene Ther 2007;14:815-8.
33. Hua H, Wang Y, Wan C, et al. Circadian gene mPer2 overexpression induces cancer cell apoptosis. Cancer Sci 2006;97:589-96.
34. Gery S, Komatsu N, Baldjyan L, Yu A, Koo D, Koeffler H. The circadian gene Per1 plays an important role in cell growth and DNA damage control in human cancer cells. Mol Cell 2006;22:375-82.
35. Yeh KT, Yang MT, Liu TC, et al. Abnormal expression of Period I (PER I) in endometrial carcinoma. J Pathol 2005;206:111-20.
36. Krugluger W, Brandstaetter A, Kallay E, et al. Regulation of genes of the circadian clock in human colon cancer: reduced period-1 and dihydropyrimidine dehydrogenase transcription correlates in high-grade tumors. Cancer Res 2007;67:7917-22.
37. Korinek V, Barker N, Morin PJ, et al. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/- colon carcinoma. Science 1997;275:1784-7.
38. Tucker J, Davis CA, Kitchens M, et al. Response to 5-fluorouracil chemotherapy is modified by dietary folic acid deficiency in ApcMin/+ mice. Cancer Lett 2002;187:153-62.